Loestrin Buyers Win Cert. In Antitrust Battle With Pharmas
A Rhode Island federal judge agreed to certify a class of Loestrin purchasers suing Warner Chilcott and Watson Pharmaceuticals for nearly $2 billion for allegedly sidelining generic alternatives to the widely...To view the full article, register now.
Already a subscriber? Click here to view full article